Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

8.60
Delayed Data
As of Sep 01
 -0.22 / -2.49%
Today’s Change
7.56
Today|||52-Week Range
18.25
-49.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues92.8M47.1M0.00165.0M
 
 
 
 
Depreciation And Amortization2.1M1.6M1.8M1.8M
 
 
 
 
 
 
Operating ExpensesGross Income90.7M45.5M-1.8M--
 
 
 
 
General Expenses129.2M144.8M125.9M171.1M
 
 
 
 
 
Research And Development108.6M118.6M97.9M143.6M
 
 
 
 
 
Total Operating Expenses131.3M146.5M127.7M172.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.5M-99.4M-127.7M-7.9M
 
 
 
 
 
Extraordinary Credit0.0046.6M0.000.00
 
 
Interest Expense On Debt1.8M1.9M0.009.6M
 
 
 
 
Other Expenses0.00193.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-40.0M-54.0M-126.8M-17.2M
 
 
 
 
 
Income Taxes0.000.000.00-183.0K
 
 
Net Income-40.0M-54.0M-126.8M-17.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.6M31.7M47.9M48.6M
 
 
 
 
 
Shares To Calculate EPS Diluted26.6M31.7M47.9M48.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.50-$1.70-$2.64-$0.36
 
 
 
 
 
EPS Diluted-$1.50-$1.70-$2.64-$0.36